Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96183 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96192 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 25MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96195 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 25MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96189 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 25MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96186 |
JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 150MG 12.5MG | TABLET | Actual shortage | 2021-04-07 | 2021-04-07 | 137069 |
SANDOZ CANDESARTAN PLUS | 32MG 12.5MG | TABLET | Resolved | 2021-01-25 | 2021-04-08 | 132389 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Actual shortage | 2019-09-26 | 2021-04-22 | 94834 |
SANDOZ CANDESARTAN PLUS | 32MG 12.5MG | TABLET | Resolved | 2021-04-20 | 2021-04-27 | 137721 |
TEVA-CILAZAPRIL/HCTZ | 5MG 12.5MG | TABLET | Resolved | 2020-10-22 | 2021-04-29 | 126948 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |